Home » Authors » Nuala Moran

Articles by Nuala Moran

HGS Gets Exclusive Development Rights To CAT Cancer Antibody

May 22, 2002

Celltech Picks Amgen To Help Advance Osteoporosis Program

May 20, 2002

Celltech Picks Amgen To Help Advance Osteoporosis Program

May 20, 2002

CAT Releases Positive Follow-Up Results In Phase II CAT-152 Trial

May 15, 2002

UK Biotech Execs Advocate Wider Public Communication

May 15, 2002

CAT Releases Positive Follow-Up Results In Phase II CAT-152 Trial

May 15, 2002

UK Biotech Execs Advocate Wider Public Communication

May 15, 2002

Proteome Sciences’ Data Show Sensitivity, Specificity In Test

May 8, 2002

MMI Raises £1.6M In Placement To Finance Start-Ups, Incubators

May 8, 2002

MMI Raises £1.6M In Placement To Finance Start-Ups, Incubators

May 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...